We are live on ! Find out more
MKA

M. Kulyk & Associates Portfolio holdings

AUM $536M
1-Year Est. Return 18.28%
This Fund
S&P 500
This Quarter Est. Return
-6.87%
1 Year Est. Return
+18.28%
3 Year Est. Return
+52.28%
5 Year Est. Return
+66.13%
10 Year Est. Return
AUM
$288M
AUM Growth
-$33.7M
Cap. Flow
-$8.06M
Cap. Flow %
-2.8%
Top 10 Hldgs %
40.72%
Holding
101
New
8
Increased
43
Reduced
29
Closed
1

Top Buys

Rank Stock Value
1
LEVI icon
Levi Strauss
LEVI
+$21.3M
2
MRK icon
Merck
MRK
+$4.16M
3
LH icon
Labcorp
LH
+$2.52M
4
WSM icon
Williams-Sonoma
WSM
+$2.44M
5
STIP icon
iShares 0-5 Year TIPS Bond ETF
STIP
+$2.26M

Sector Composition

Rank Sector Weight
1 Technology 19.71%
2 Consumer Discretionary 12.54%
3 Healthcare 10.23%
4 Consumer Staples 10.19%
5 Financials 10.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STIP icon
1
iShares 0-5 Year TIPS Bond ETF
STIP
$15.8B
$36.7M 12.75%
381,491
+22,585
+6% +$2.26M
LEVI icon
2
Levi Strauss
LEVI
$9.44B
$18.2M 6.32%
1,256,999
+1,195,475
+1,943% +$21.3M
AAPL icon
3
Apple
AAPL
$4.89T
$9.29M 3.23%
67,250
-499
-0.7% -$78.3K
MSFT icon
4
Microsoft
MSFT
$2.84T
$8.89M 3.09%
38,183
+896
+2% +$237K
RY icon
5
Royal Bank of Canada
RY
$291B
$8.67M 3.02%
96,326
+6,391
+7% +$613K
HD icon
6
Home Depot
HD
$332B
$8.14M 2.83%
29,495
+354
+1% +$104K
CSCO icon
7
Cisco
CSCO
$450B
$7.39M 2.57%
184,856
+11,336
+7% +$503K
TD icon
8
Toronto Dominion Bank
TD
$198B
$7.21M 2.51%
117,492
+8,682
+8% +$562K
NGG icon
9
National Grid
NGG
$81.9B
$6.49M 2.26%
135,858
-13,882
-9% -$835K
GOOGL icon
10
Alphabet (Google) Class A
GOOGL
$3.91T
$6.18M 2.15%
64,572
+18,452
+40% +$2.05M
PG icon
11
Procter & Gamble
PG
$343B
$5.48M 1.9%
43,390
+326
+0.8% +$46.3K
TSM icon
12
TSMC
TSM
$2.09T
$5.46M 1.9%
79,665
+21,404
+37% +$1.77M
GILD icon
13
Gilead Sciences
GILD
$161B
$5.43M 1.89%
88,042
+1,572
+2% +$99.1K
AMT icon
14
American Tower
AMT
$77.7B
$5.24M 1.82%
24,401
-3,649
-13% -$938K
GIS icon
15
General Mills
GIS
$19.2B
$5.01M 1.74%
65,466
-34,071
-34% -$2.6M
PLD icon
16
Prologis
PLD
$138B
$4.85M 1.69%
47,716
-1,750
-4% -$217K
AMGN icon
17
Amgen
AMGN
$203B
$4.83M 1.68%
21,424
+401
+2% +$97.2K
NVDA icon
18
NVIDIA
NVDA
$5.01T
$4.66M 1.62%
384,110
+101,310
+36% +$1.6M
CSX icon
19
CSX Corp
CSX
$98.6B
$4.66M 1.62%
174,857
+3,361
+2% +$104K
ACN icon
20
Accenture
ACN
$89.9B
$4.61M 1.6%
17,901
+496
+3% +$143K
V icon
21
Visa
V
$677B
$4.55M 1.58%
25,625
+828
+3% +$168K
JCI icon
22
Johnson Controls International
JCI
$87.5B
$4.4M 1.53%
89,371
+4,465
+5% +$237K
INTU icon
23
Intuit
INTU
$81.1B
$4.38M 1.52%
11,310
+408
+4% +$176K
ECL icon
24
Ecolab
ECL
$75.6B
$4.24M 1.47%
29,357
-648
-2% -$105K
ZTS icon
25
Zoetis
ZTS
$31.6B
$4.08M 1.42%
27,533
+1,341
+5% +$224K

Similar funds

M. Kulyk & Associates's Q3 2022 Portfolio in Review

As of Q3 2022, M. Kulyk & Associates held 101 positions worth $288M, down 10% from $321M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

M. Kulyk & Associates's Q3 2022 filing shows 8 new, 43 increased, 29 reduced and 1 closed positions. Its largest new stake was Merck: 46,558 shares worth $4.01M. The largest sale was State Street SPDR Portfolio Short Term Treasury ETF, an estimated $38.4M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • M. Kulyk & Associates's largest Q3 2022 buy was Merck: 46,558 shares worth $4.01M.
  • M. Kulyk & Associates added most to Levi Strauss in Q3 2022, an estimated $21.3M increase.
  • M. Kulyk & Associates's biggest Q3 2022 reduction was State Street SPDR Portfolio Short Term Treasury ETF, cutting an estimated $38.4M.
  • M. Kulyk & Associates fully exited Vanguard Dividend Appreciation ETF in Q3 2022, selling an estimated $510K.
  • M. Kulyk & Associates's ten largest holdings make up 41% of its $288M portfolio in Q3 2022.
  • M. Kulyk & Associates opened 8 new positions and closed 1 in Q3 2022.
  • M. Kulyk & Associates's portfolio value fell 10% quarter-over-quarter to $288M.

Based on M. Kulyk & Associates's 13F filing for Q3 2022, filed 7 Nov 2022.